Fecha de vigencia | Policy Name | Reviewed Date |
1/1/2024 |
ADHD Long Acting Stimulants
| 9/20/2023 |
1/1/2024 |
Adlarity® (donepezil) transdermal patch
| 6/21/2023 |
1/1/2024 |
Aemcolo® (rifamycin)
| 6/21/2023 |
1/1/2024 |
Afinitor/Afinitor Disperz (everolimus)
| 9/20/2023 |
1/1/2024 |
Akynzeo (fosnetupitant/netupitant-palonosetron)
| 6/21/2023 |
1/1/2024 |
Allergy Ophthalmics
| 6/21/2023 |
1/1/2024 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Prolastin-C®)
| 7/19/2023 |
1/1/2024 |
Alpha-1 Proteinase Inhibitors (Prolastin-C®, Zemaira®)
| 9/20/2023 |
1/1/2024 |
Alphagan® P (brimonidine)
| 9/20/2023 |
1/1/2024 |
Amitiza® (lubiprostone)
| 6/21/2023 |
1/1/2024 |
Angiotensin Blocking & Renin Inhibitor Agents
| 8/16/2023 |
1/1/2024 |
Aptiom® (eslicarbazepine acetate)
| 6/21/2023 |
1/1/2024 |
Astagraf XL (tacrolimus extended release)
| 8/16/2023 |
1/1/2024 |
Atgam (antithymocyte immune globulin, equine)
| 6/21/2023 |
1/1/2024 |
Azopt® (brinzolamide ophthalmic suspension) 1%
| 9/20/2023 |
1/1/2024 |
Beovu® (brolucizumab)
| 9/20/2023 |
1/1/2024 |
Berinert (C1 esterase inhibitor, human)
| 7/19/2023 |
1/1/2024 |
Berinert (C1 esterase inhibitor, human)
| 7/19/2023 |
1/1/2024 |
Bevacizumab products
| 7/19/2023 |
1/1/2024 |
Botox® (onabotulinumtoxinA)
| 8/31/2023 |
1/1/2024 |
Bowel Prep Agents
| 7/20/2023 |
1/1/2024 |
Breztri Aerosphere™ (budesonide/glycopyrrolate/formoterol fumarate)
| 8/16/2023 |
1/1/2024 |
Briviact® (brivaracetam)
| 6/21/2023 |
1/1/2024 |
Byooviz™ (ranibizumab-nuna)
| 8/16/2023 |
1/1/2024 |
Byooviz™ (ranibizumab-nuna)
| 11/15/2023 |
1/1/2024 |
Calcium Channel Blocking Agents
| 6/21/2023 |
1/1/2024 |
Caplyta (lumateperone)
| 10/18/2023 |
1/1/2024 |
Caprelsa (vandetanib)
| 6/21/2023 |
1/1/2024 |
CaroSpir® (spironolactone) oral suspension
| 6/21/2023 |
1/1/2024 |
Cialis (tadalafil)
| 8/16/2023 |
1/1/2024 |
Cinryze (C1 esterase inhibitor, human)
| 7/19/2023 |
1/1/2024 |
Cinryze (C1 esterase inhibitor, human)
| 7/19/2023 |
1/1/2024 |
Cometriq (cabozantinib)
| 7/19/2023 |
1/1/2024 |
Corticotropin Products
| 6/21/2023 |
1/1/2024 |
DPP-IV inhibitors
| 6/21/2023 |
1/1/2024 |
DPP-IV, SGLT2 Combination Products
| 8/16/2023 |
1/1/2024 |
DPP-IV, SGLT2 Combination Products
| 6/21/2023 |
1/1/2024 |
Daxxify® (daxibotulinumtoxinA-lanm)
| 9/20/2023 |
1/1/2024 |
Deferasirox products
| 10/18/2023 |
1/1/2024 |
Duavee® (conjugated estrogens/bazedoxifene tablet)
| 6/21/2023 |
1/1/2024 |
Duopa® (carbidopa and levodopa) enteral suspension
| 6/21/2023 |
1/1/2024 |
Dupixent® (dupilumab) injection
| 8/16/2023 |
1/1/2024 |
Dupixent® (dupilumab) injection
| 8/16/2023 |
1/1/2024 |
Dysport® (abobotulinumtoxinA)
| 8/16/2023 |
1/1/2024 |
Elidel® (pimecrolimus)
| 6/21/2023 |
1/1/2024 |
Emgality® (galcanezumab)
| 8/16/2023 |
1/1/2024 |
Empaveli (pegcetacoplan)
| 7/19/2023 |
1/1/2024 |
Entadfi (finasteride and tadalafil)
| 8/16/2023 |
1/1/2024 |
Epidiolex® (cannabidiol)
| 7/19/2023 |
1/1/2024 |
Eplerenone Products
| 6/21/2023 |
1/1/2024 |
Epoprostenol Products
| 6/21/2023 |
1/1/2024 |
Erbitux (cetuximab)
| 6/21/2023 |
1/1/2024 |
Ferriprox® (deferiprone)
| 10/18/2023 |
1/1/2024 |
Fintepla® (fenfluramine)
| 7/19/2023 |
1/1/2024 |
Firazyr (icatibant)
| 7/19/2023 |
1/1/2024 |
Haegarda (C1 esterase inhibitor, human)
| 7/19/2023 |
1/1/2024 |
Helicobacter Pylori Agents
| 6/21/2023 |
1/1/2024 |
IVIG (immune globulin)
| 6/21/2023 |
1/1/2024 |
Ibrance (palbociclib)
| 6/21/2023 |
1/1/2024 |
Ibsrela® (tenapanor)
| 9/20/2023 |
1/1/2024 |
Inhaled Corticosteroid and Long-Acting Beta Agonist (ICS/LABA) Inhalers
| 7/19/2023 |
1/1/2024 |
Inhaled Corticosteroid and Long-Acting Beta Agonist (ICS/LABA) Inhalers
| 7/19/2023 |
1/1/2024 |
Inhaled Corticosteroids
| 7/19/2023 |
1/1/2024 |
Inlyta (axtinib)
| 6/21/2023 |
1/1/2024 |
Intranasal Rhinitis Agents
| 9/20/2023 |
1/1/2024 |
Intravenous Iron Products
| 9/20/2023 |
1/1/2024 |
Iressa (gefitinib)
| 7/19/2023 |
1/1/2024 |
Kalbitor (ecallantide)
| 7/19/2023 |
1/1/2024 |
Kalbitor (ecallantide)
| 7/19/2023 |
1/1/2024 |
Kisqali (ribociclib)
| 6/21/2023 |
1/1/2024 |
Lenvima (lenvatinib)
| 7/19/2023 |
1/1/2024 |
Levothyroxine Products
| 8/16/2023 |
1/1/2024 |
Long Acting Anticholinergics
| 6/21/2023 |
1/1/2024 |
Long Acting Beta Agonists
| 6/21/2023 |
1/1/2024 |
Long Acting Insulins
| 7/19/2023 |
1/1/2024 |
Long Acting Opioids
| 9/20/2023 |
1/1/2024 |
Lorbrena (lorlatinib)
| 7/19/2023 |
1/1/2024 |
Lucentis® (ranibizumab)
| 8/16/2023 |
1/1/2024 |
Lumakras (sotorasib)
| 7/19/2023 |
1/1/2024 |
Lybalvi (olanzapine and samidorphan)
| 11/15/2023 |
1/1/2024 |
Mavenclad® (cladribine)
| 9/20/2023 |
1/1/2024 |
Mavenclad® (cladribine)
| 7/19/2023 |
1/1/2024 |
Motegrity® (prucalopride)
| 6/21/2023 |
1/1/2024 |
Myobloc® (rimabotulinumtoxinB)
| 8/31/2023 |
1/1/2024 |
Namenda XR® (memantine extended-release)
| 8/16/2023 |
1/1/2024 |
Nexavar (sorafenib)
| 7/19/2023 |
1/1/2024 |
Non-Preferred Continuous Glucose Monitoring Systems
| 10/18/2023 |
1/1/2024 |
Non-Preferred Infliximab Products - Renflexis (infliximab-abda), Avsola (infliximab-axxq)
| 9/20/2023 |
1/1/2024 |
Non-Preferred Infliximab Products - Renflexis (infliximab-abda), Avsola (infliximab-axxq), Remicade (infliximab), unbranded Infliximab
| 6/21/2023 |
1/1/2024 |
Non-Preferred Infliximab products - Renflexis (infliximab-abda) and Avsola (infliximab-axxq)
| 9/20/2023 |
1/1/2024 |
Non-Preferred Multiple Sclerosis Interferons
| 6/21/2023 |
1/1/2024 |
Non-Preferred Oral Multiple Sclerosis Products
| 8/16/2023 |
1/1/2024 |
Non-Preferred Oral Multiple Sclerosis Products
| 6/21/2023 |
1/1/2024 |
Non-preferred Pegfilgrastim Products - Fylnetra (pegfilgrastim-pbbk), Nyvepria (pegfilgrastim-apfg), Stimufend (pegfilgrastim-fpgk), and Udenyca (pegfilgrastim-cbqv)
| 7/19/2023 |
1/1/2024 |
Nonsteroidal Anti-Inflammatory Drug Products
| 9/20/2023 |
1/1/2024 |
Nonsteroidal Anti-Inflammatory Drug Products
| 7/19/2023 |
1/1/2024 |
Nurtec™ ODT (rimegepant)
| 6/21/2023 |
1/1/2024 |
Ocaliva® (obeticholic acid)
| 6/21/2023 |
1/1/2024 |
Ocrevus® (ocrelizumab)
| 7/19/2023 |
1/1/2024 |
Ocrevus® (ocrelizumab)
| 8/16/2023 |
1/1/2024 |
Octreotide Products
| 8/16/2023 |
1/1/2024 |
Ofev® (nintedanib)
| 8/16/2023 |
1/1/2024 |
Onfi® (clobazam)
| 7/19/2023 |
1/1/2024 |
Ophthalmic Antibiotics
| 9/20/2023 |
1/1/2024 |
Ophthalmic Beta Blockers
| 9/20/2023 |
1/1/2024 |
Ophthalmic Prostaglandins
| 8/31/2023 |
1/1/2024 |
Ophthalmic Steroids
| 6/21/2023 |
1/1/2024 |
Orladeyo (berotralstat)
| 7/19/2023 |
1/1/2024 |
Pegasys (peginterferon alpha-2a)
| 6/21/2023 |
1/1/2024 |
Prandial and Intermediate Acting Insulins
| 7/19/2023 |
1/1/2024 |
Preferred Continuous Glucose Monitoring Systems
| 10/18/2023 |
1/1/2024 |
Preferred Infliximab Products - Inflectra (infliximab-dyyb)
| 9/20/2023 |
1/1/2024 |
Preferred Infliximab Products - Remicade (infliximab), Inflectra (infliximab-dyyb), and infliximab
| 9/20/2023 |
1/1/2024 |
Preferred Infliximab Products - Remicade (infliximab), Inflectra (infliximab-dyyb), and infliximab
| 6/21/2023 |
1/1/2024 |
Preferred Multiple Sclerosis Products
| 8/16/2023 |
1/1/2024 |
Preferred Multiple Sclerosis Products
| 6/21/2023 |
1/1/2024 |
Preferred Pegfilgrastim Products - Neulasta (pegfilgrastim), Fulphila (pegfilgrastim-jmdb), and Ziextenzo (pegfilgrastim-bmez)
| 7/19/2023 |
1/1/2024 |
Prialt® (ziconotide intrathecal infusion)
| 6/21/2023 |
1/1/2024 |
Inhibidores de la bomba de protones
| 8/16/2023 |
1/1/2024 |
Qelbree (viloxazine)
| 9/20/2023 |
1/1/2024 |
Quviviq (daridorexant)
| 9/20/2023 |
1/1/2024 |
Radicava® and Radicava ORS® (edaravone)
| 7/19/2023 |
1/1/2024 |
Relistor® (methylnaltrexone)
| 6/21/2023 |
1/1/2024 |
Relyvrio™ (sodium phenylbutyrate/taurursodiol)
| 7/19/2023 |
1/1/2024 |
Remodulin® (treprostinil)
| 6/21/2023 |
1/1/2024 |
Rexulti (brexpiprazole)
| 11/15/2023 |
1/1/2024 |
Reyvow™ (lasmiditan)
| 6/21/2023 |
1/1/2024 |
Rinvoq (upadacitinib)
| 11/15/2023 |
1/1/2024 |
Rituximab products
| 8/16/2023 |
1/1/2024 |
Rocklatan® (netarsudil and latanoprost)
| 9/20/2023 |
1/1/2024 |
Ruconest (C1 esterase inhibitor, recombinant)
| 7/19/2023 |
1/1/2024 |
Ruconest (C1 esterase inhibitor, recombinant)
| 7/19/2023 |
1/1/2024 |
Sabril (vigabatrin)
| 7/19/2023 |
1/1/2024 |
Sandostatin® S.C., Sandostatin LAR® Depot (octreotide acetate for injection)
| 9/20/2023 |
1/1/2024 |
Seroquel XR (quetiapine fumarate) extended release tablets
| 8/16/2023 |
1/1/2024 |
Signifor® LAR (pasireotide)
| 7/19/2023 |
1/1/2024 |
Simbrinza™ (brinzolamide/brimonidine ophthalmic suspension)
| 9/20/2023 |
1/1/2024 |
Soliris® (eculizumab)

| 7/19/2023 |
1/1/2024 |
Somatuline® Depot (lanreotide)
| 7/19/2023 |
1/1/2024 |
Spinraza® (nusinersen)
| 6/21/2023 |
1/1/2024 |
Spiriva Handihaler® (tiotropium bromide) ETB
| 9/20/2023 |
1/1/2024 |
Stivarga (regorafenib)
| 10/12/2023 |
1/1/2024 |
Susvimo™ (ranibizumab)
| 9/20/2023 |
1/1/2024 |
Susvimo™ (ranibizumab)
| 8/16/2023 |
1/1/2024 |
Sutent (sunitinib)
| 7/19/2023 |
1/1/2024 |
Symproic® (naldemedine)
| 6/21/2023 |
1/1/2024 |
Syndros (dronabinol) oral solution
| 6/21/2023 |
1/1/2024 |
Tagrisso (osimertinib)
| 7/19/2023 |
1/1/2024 |
Takhzyro (lanadelumab-flyo)
| 7/19/2023 |
1/1/2024 |
Takhzyro (lanadelumab-flyo)
| 7/19/2023 |
1/1/2024 |
Tarceva (erlotinib)
| 6/21/2023 |
1/1/2024 |
Tasmar® (tolcapone)
| 6/21/2023 |
1/1/2024 |
Thymoglobulin (antithymocyte globulin [rabbit])
| 6/21/2023 |
1/1/2024 |
Tivdak (tisotumab vedotin-tftv)
| 9/20/2023 |
1/1/2024 |
Tobramycin for Inhalation
| 10/18/2023 |
1/1/2024 |
Topical Estradiol Products
| 8/16/2023 |
1/1/2024 |
Topical Vitamin D Products
| 8/31/2023 |
1/1/2024 |
Torisel (temsirolimus)
| 9/20/2023 |
1/1/2024 |
Trastuzumab Products
| 7/19/2023 |
1/1/2024 |
Trelstar (triptorelin pamoate)
| 8/16/2023 |
1/1/2024 |
Triptans
| 9/20/2023 |
1/1/2024 |
Trulance® (plecanatide)
| 9/20/2023 |
1/1/2024 |
Tysabri® (natalizumab)
| 7/19/2023 |
1/1/2024 |
Tysabri® (natalizumab)
| 8/16/2023 |
1/1/2024 |
Tyvaso® (treprostinil)

| 6/21/2023 |
1/1/2024 |
Ubrelvy™ (ubrogepant)
| 6/21/2023 |
1/1/2024 |
Varizig (varicella zoster immune globulin)
| 6/21/2023 |
1/1/2024 |
Varubi (rolapitant)
| 6/21/2023 |
1/1/2024 |
Vectibix (panitumumab)
| 6/21/2023 |
1/1/2024 |
Ventavis® (iloprost)
| 6/21/2023 |
1/1/2024 |
Verzenio (abemaciclib)
| 7/19/2023 |
1/1/2024 |
Vesicare and Vesicare LS (solifenacin)
| 8/16/2023 |
1/1/2024 |
Vigabatrin products
| 7/19/2023 |
1/1/2024 |
Viibryd (vilazodone)
| 8/16/2023 |
1/1/2024 |
Viscosupplements

| 8/16/2023 |
1/1/2024 |
Viscosupplements
| 7/19/2023 |
1/1/2024 |
Visudyne® (verteporfin)
| 8/16/2023 |
1/1/2024 |
Vizimpro (dacomitinib)
| 7/19/2023 |
1/1/2024 |
Votrient (pazopanib)

| 7/19/2023 |
1/1/2024 |
Vraylar (cariprazine)
| 10/18/2023 |
1/1/2024 |
Vyepti™ (eptinezumab)
| 8/16/2023 |
1/1/2024 |
Xalkori (crizotinib)
| 7/19/2023 |
1/1/2024 |
Xatmep™ (methotrexate) oral solution
| 6/21/2023 |
1/1/2024 |
Xeomin® (incobotulinumtoxinA)
| 8/16/2023 |
1/1/2024 |
Xgeva (denosumab)
| 9/20/2023 |
1/1/2024 |
Xifaxan® (rifaximin)
| 7/19/2023 |
1/1/2024 |
Xifaxan® (rifaximin)
| 6/21/2023 |
1/1/2024 |
Xolair® (omalizumab)
| 8/16/2023 |
1/1/2024 |
Xyrem (sodium oxybate)
| 9/20/2023 |
1/1/2024 |
Xywav (calcium, magnesium, potassium, and sodium oxybates)
| 8/16/2023 |
1/1/2024 |
Zaltrap (ziv-aflibercept)
| 7/19/2023 |
1/1/2024 |
Zavzpret™ (zavegepant)
| 7/19/2023 |
1/1/2024 |
Zemaira® (alpha-1 proteinase inhibitor)
| 7/19/2023 |
1/1/2024 |
Zeposia® (ozanimod)
| 9/20/2023 |
1/1/2024 |
Zilretta™ (triamcinolone acetonide extended-release injectable suspension)
| 6/21/2023 |
11/22/2023 |
Brixadi™ (buprenorphine)
| 11/15/2023 |
11/22/2023 |
Cosentyx (secukinumab) intravenous solution
| 11/15/2023 |
11/22/2023 |
Cosentyx (secukinumab) intravenous solution

| 11/30/2023 |
11/22/2023 |
Cosentyx (secukinumab) intravenous solution

| 11/30/2023 |
11/22/2023 |
Entyvio® (vedolizumab)

| 11/15/2023 |
11/22/2023 |
Entyvio® (vedolizumab)

| 11/15/2023 |
11/22/2023 |
Entyvio® (vedolizumab)

| 11/15/2023 |
11/22/2023 |
Ilumya® (tildrakizumab)

| 9/20/2023 |
11/22/2023 |
Ilumya® (tildrakizumab)

| 9/20/2023 |
11/22/2023 |
Ilumya™ (tildrakizumab)

| 9/20/2023 |
11/22/2023 |
Motpoly XR (lacosamide extended release)
| 11/15/2023 |
11/22/2023 |
Non-Preferred Adalimumab Products

| 11/15/2023 |
11/22/2023 |
Non-Preferred Adalimumab Products

| 11/15/2023 |
11/22/2023 |
Rystiggo (rozanolixizumab-noli)
| 11/15/2023 |
11/22/2023 |
Talvey (talquetamab)
| 11/15/2023 |
11/22/2023 |
Xdemvy™ (lotilaner)
| 11/15/2023 |
11/22/2023 |
Ycanth™ (cantharidin)
| 11/15/2023 |
11/15/2023 |
Akeega (niraparib and abiraterone acetate)
| 11/15/2023 |
11/15/2023 |
Elrexfio (elranatamab-bcmm)
| 11/15/2023 |
11/8/2023 |
Ojjaara (momelotinib)
| 11/2/2023 |
10/25/2023 |
AIRSUPRA (albuterol and budesonide) inhalation aerosol
| 10/18/2023 |
10/25/2023 |
Vowst (fecal microbiota spores, live-brpk)
| 10/18/2023 |
10/18/2023 |
Vanflyta (quizartinib)
| 10/18/2023 |
10/13/2023 |
Non-Preferred Adalimumab Products
| 9/20/2023 |
10/13/2023 |
Preferred Adalimumab Products
| 9/20/2023 |
10/13/2023 |
Preferred Adalimumab Products
| 9/20/2023 |
10/13/2023 |
Preferred Adalimumab Products

| 11/21/2023 |
10/1/2023 |
Cimerli™ (ranibizumab-eqrn)
| 8/16/2023 |
10/1/2023 |
Daxxify® (daxibotulinumtoxinA-lanm)
| 9/20/2023 |
9/27/2023 |
Columvi™ (glofitamab-gxbm)
| 9/20/2023 |
9/27/2023 |
Elevidys (delandistrogene moxeparvovec-rokl)
| 10/18/2023 |
9/27/2023 |
Izervay™ (avacincaptad pegol)
| 9/20/2023 |
9/27/2023 |
Joenja® (leniolisib)
| 9/20/2023 |
9/27/2023 |
Litfulo™ (ritlecitinib)
| 9/20/2023 |
9/27/2023 |
Vyjuvek™ (beremagene geperpavec-svdt)
| 9/20/2023 |
9/4/2023 |
Adstiladrin (nadofaragene firadenovec-vncg)
| 8/24/2023 |
8/31/2023 |
Roctavian™ (valoctocogene roxaparvovec-rvox)
| 8/24/2023 |
8/23/2023 |
Epkinly™ (epcoritamab-bysp)
| 8/16/2023 |
8/23/2023 |
Filspari (sparsentan)
| 8/16/2023 |
8/23/2023 |
Inpefa™ (sotagliflozin)
| 8/16/2023 |
8/23/2023 |
LAMZEDE® (velmanase alfa-tycv)
| 8/16/2023 |
8/23/2023 |
LAMZEDE® (velmanase alfa-tycv)
| 8/16/2023 |
8/23/2023 |
Leqembi™ (lecanemab-irmb)
| 9/20/2023 |
8/23/2023 |
Miebo™ (perfluorohexyloctane ophthalmic solution)
| 8/16/2023 |
8/23/2023 |
Miebo™ (perfluorohexyloctane ophthalmic solution)
| 8/16/2023 |
8/23/2023 |
Rezzayo Intravenous Solution
| 8/16/2023 |
8/23/2023 |
Rezzayo Intravenous Solution
| 8/16/2023 |
8/23/2023 |
Rezzayo Intravenous Solution
| 8/16/2023 |
7/26/2023 |
Lumryz (sodium oxybate)
| 7/19/2023 |
7/26/2023 |
Lumryz (sodium oxybate)
| 7/19/2023 |
7/26/2023 |
Non-Preferred Adalimumab Biosimilar Products
| 7/19/2023 |
7/26/2023 |
Site of Care for Injectable Drugs
| 6/29/2023 |
7/26/2023 |
Veozah™ (fezolinetant)
| 7/19/2023 |
7/26/2023 |
Zavzpret™ (zavegepant)
| 7/19/2023 |
7/26/2023 |
Zavzpret™ (zavegepant)
| 7/19/2023 |
6/28/2023 |
Qalsody™ (tofersen)
| 6/21/2023 |
6/28/2023 |
Skyclarys™ (omaveloxolone)
| 6/21/2023 |
6/7/2023 |
Briumvi™ (ublituximab) intravenous solution
| 5/17/2023 |
6/7/2023 |
Briumvi™ (ublituximab) intravenous solution
| 5/17/2023 |
6/7/2023 |
Briumvi™ (ublituximab) intravenous solution
| 5/17/2023 |
6/1/2023 |
Hemgenix (etranacogene dezaparvovec-drlb)
| 5/25/2023 |
5/24/2023 |
Cuvrior™ (trientine tetrahydrochloride) tablets
| 5/17/2023 |
5/24/2023 |
Daybue™ (trofinetide) oral solution
| 5/17/2023 |
5/24/2023 |
Igalmi™ (dexmedetomidine)
| 5/17/2023 |
5/24/2023 |
Syfovre™ (pegcetacoplan) intravitreal solution
| 5/17/2023 |
5/24/2023 |
Zynyz (retifanlimab-dlwr)
| 5/17/2023 |
4/26/2023 |
Jaypirca (pirtobrutinib)
| 4/19/2023 |
4/26/2023 |
Pradaxa® (dabigatran etexilate) oral pellet
| 4/19/2023 |
4/26/2023 |
Tzield© (teplizumab) intravenous solution
| 4/19/2023 |
4/19/2023 |
Orserdu (elacestrant)
| 3/30/2023 |
3/23/2023 |
Continuidad de la atención
| 3/23/2023 |
3/22/2023 |
Krazati (adagrasib)
| 3/2/2023 |
3/22/2023 |
Lunsumio (mosunetuzumab-axgb)
| 3/15/2023 |
3/22/2023 |
Sunlenca (lenacapavir)
| 3/15/2023 |
3/1/2023 |
Productos Bevacizumab
| 2/23/2023 |
2/22/2023 |
Relyvrio™ (sodium phenylbutyrate/taurursodiol)
| 2/15/2023 |
2/22/2023 |
Rezlidhia (olutasidenib)
| 2/15/2023 |
2/22/2023 |
Sotyktu (deucravacitinib)
| 9/20/2023 |
2/22/2023 |
Sotyktu (deucravacitinib)
| 9/20/2023 |
2/15/2023 |
Imjudo (tremelimumab-actl)
| 1/19/2023 |
2/15/2023 |
Lytgobi (futibatinib)
| 1/19/2023 |
1/25/2023 |
Rebyota™ (fecal microbiota, live-jslm)
| 1/18/2023 |
1/25/2023 |
Tascenso ODT™ (fingolimod)
| 1/18/2023 |
1/1/2023 |
Abecma® (idecabtagene vicleucel)
| 4/19/2023 |
1/1/2023 |
Abraxane (nab) paclitaxel
| 6/29/2023 |
1/1/2023 |
Abraxane (nab) paclitaxel
| 5/17/2023 |
1/1/2023 |
Abraxane (nab- paclitaxel)
| 5/17/2023 |
1/1/2023 |
Aemcolo® (rifamycin)
| 3/15/2023 |
1/1/2023 |
Afinitor/Afinitor Disperz (everolimus)
| 5/17/2023 |
1/1/2023 |
Aflibercept Products (Eylea®, Eylea® HD)
| 10/5/2023 |
1/1/2023 |
Aklief® (trifarotene)
| 5/17/2023 |
1/1/2023 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Zemaira®)
| 9/20/2023 |
1/1/2023 |
Amitiza® (lubiprostone)
| 5/17/2023 |
1/1/2023 |
Amzeeq (minocycline) topical foam
| 5/17/2023 |
1/1/2023 |
Angiotensin Blocking Agents
| 5/17/2023 |
1/1/2023 |
Aranesp® (darbepoetin alfa)
| 7/19/2023 |
1/1/2023 |
Aubagio® (teriflunomide) tablet
| 3/16/2023 |
1/1/2023 |
Auryxia® (ferric citrate)
| 3/15/2023 |
1/1/2023 |
Avsola® (infliximab-axxq)
| 9/20/2023 |
1/1/2023 |
Bafiertam® (monomethyl fumarate) capsule, delayed release
| 5/17/2023 |
1/1/2023 |
Bendamustine products (Treanda, Bendeka, Belrapzo, Vivimusta)
| 8/3/2023 |
1/1/2023 |
Beovu® (brolucizumab)
| 4/19/2023 |
1/1/2023 |
Bevacizumab products
| 2/23/2023 |
1/1/2023 |
Bowel Prep Agents
| 7/20/2023 |
1/1/2023 |
Breyanzi® (lisocabtagene maraleucel)
| 4/19/2023 |
1/1/2023 |
Brukinsa™ (zanubrutinib)
| 2/16/2023 |
1/1/2023 |
Buprenorphine Containing Products
| 8/16/2023 |
1/1/2023 |
CFTR Modulators
| 6/21/2023 |
1/1/2023 |
Carvykti™ (ciltacabtagene autoleucel)
| 4/19/2023 |
1/1/2023 |
Cholbam® (cholic acid)
| 9/20/2023 |
1/1/2023 |
DPP-IV, SGLT2 Combination Products
| 7/19/2023 |
1/1/2023 |
Deferasirox Products
| 10/18/2023 |
1/1/2023 |
Deferasirox Tablet
| 10/18/2023 |
1/1/2023 |
Dexilant® (dexlansoprazole)
| 5/17/2023 |
1/1/2023 |
Diacomit® (stiripentol)

| 11/15/2023 |
1/1/2023 |
Differin® (adapalene) and Epiduo® (adapalene and benzoyl peroxide)
| 5/17/2023 |
1/1/2023 |
Dopamine Agonists
| 8/16/2023 |
1/1/2023 |
Dysport® (abobotulinumtoxinA)
| 8/16/2023 |
1/1/2023 |
Elahere (mirvetuximab soravtansine-gynx)
| 6/8/2023 |
1/1/2023 |
Elzonris™ (tagraxofusp-erzs)
| 5/17/2023 |
1/1/2023 |
Enhertu (fam-trastuzumab deruxtecan-nxki)
| 9/20/2023 |
1/1/2023 |
Eplerenone Products
| 7/19/2023 |
1/1/2023 |
Epoetin Alfa (Epogen, Procrit, Retacrit)
| 10/18/2023 |
1/1/2023 |
Esbriet® (pirfenidone)
| 7/19/2023 |
1/1/2023 |
Eulexin (Flutamide)
| 5/17/2023 |
1/1/2023 |
Evenity™ (romosozumab-aqqg)
| 5/17/2023 |
1/1/2023 |
Eysuvis™ (loteprednol etabonate)
| 3/15/2023 |
1/1/2023 |
Finacea® (azelaic acid) topical foam
| 9/20/2023 |
1/1/2023 |
Fintepla® (fenfluramine)
| 8/16/2023 |
1/1/2023 |
Fycompa® (perampanel)
| 3/15/2023 |
1/1/2023 |
Gloperba® (colchicine) Oral solution
| 2/15/2023 |
1/1/2023 |
Helicobacter Pylori Agents
| 4/19/2023 |
1/1/2023 |
Herceptin Hylecta (trastuzumab and hyaluronidase-oysk)
| 5/17/2023 |
1/1/2023 |
Herceptin Hylecta (trastuzumab and hyaluronidase-oysk)
| 5/17/2023 |
1/1/2023 |
Hypomethylating agents (azacitidine, decitabine)
| 8/16/2023 |
1/1/2023 |
Ibrance (palbociclib)
|